Introduction
Apoptosis is a genetically regulated cell death that functions not only to eliminate unnecessary cells during normal development and tissue turnover, but also as a cellular defense mechanism against oncogene expression and virus infection. In virus infection, apoptosis triggered early in infection results in reduced production of progeny virions and exclusion of the infected cells from the organism. To cope with cellular antiviral mechanisms associated with apoptosis induction, many viruses have evolved various genes whose products are able to ablate the apoptotic pathway to maximize their multiplication in infected cells (Everett and McFadden, 2001; Razvi and Welsh, 1995; Roulston et al., 1999; Teodoro and Branton, 1997) . In baculoviruses, two types of antiapoptotic genes, p35 and inhibitor of apoptosis (iap), have been identified (Clem, 2001) .
p35 homologues have been found in Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV), Bombyx mori NPV (BmNPV), and Trichoplusia ni MNPV (TnMNPV), and characterized to encode an inhibitor of effector caspase, a cysteine protease, that is activated upon protein cleavage by upstream initiator caspases and functions as the executioner of apoptosis (Clem, 2001; Clem et al., 1991; Dai et al., 1999; Kamita et al., 1993) . Recently, p49 was identified from Spodoptera littoralis MNPV as a second member of the p35 family (Du et al., 1999; Pei et al., 2002) . P49 inhibits upstream initiator caspase, in addition to effector caspase, in the apoptotic pathway (Jabbour et al., 2002) .
In contrast to the genes of the p35 family that are present only in certain NPVs, iaps are encoded by genomes of all lepidopteran baculoviruses so far sequenced. Baculovirus IAPs are currently classified into five members, IAP1 -IAP5, based on amino acid sequence homology (Luque et al., 2001; Maguire et al., 2000) . Functional analyses have revealed that only IAP3 is capable of blocking apoptosis in Cydia pomonella granulovirus (CpGV) (Crook et al., 1993; Vilaplana and O'Reilly, 2003) and Orgyia pseudotsugata MNPV (OpMNPV) (Birnbaum et al., 1994; Means et al., 2003) , although these viruses possess three and four iaps, respectively. Whereas only IAP1 and IAP2, but not IAP3 and IAP4, exhibit anti-apoptotic activity in Epiphyas postvittana MNPV (EppoMNPV) (Maguire et al., 2000) . Al-though it is documented that two baculovirus iap repeat (BIR) domains in the N-terminal region and a RING finger motif in the C-terminal region (Birnbaum et al., 1994; Crook et al., 1993; Miller, 1999; Salvesen and Duckett, 2002) are essential for anti-apoptotic activity of baculovirus IAPs Hozak et al., 2000; Huang et al., 2000; Vucic et al., 1998; Wright and Clem, 2002) , molecular mechanisms underlying blockage of apoptosis by baculovirus IAPs have not been well defined.
Recently, IAPs have also been identified in lepidopteran insects that include Tricoplusia ni (Seshagiri et al., 1999) , Spodoptera frugiperda (Huang et al., 2000) , and Bombyx mori (Huang et al., 2001) . Phylogenetic analysis suggested that baculovirus iaps were derived from insect hosts (Huang et al., 2000; Hughes, 2002) . Such analysis further showed that iap3 of NPV was acquired from the insect host through a gene capture event that was different from those involved in the gene capture by a possible ancestor of other NPV iaps, suggesting that NPV IAPs other than IAP3 might have been evolved to play functional roles distinct from that of IAP3 in infected insect cells.
We have previously shown that Ld652Y cells infected with Hyphantria cunea NPV (HycuNPV) undergo severe apoptosis, producing no detectable budded virions (BVs) and polyhedrin (Ishikawa et al., 2003) . In the present study, we show that HycuNPV does not possess the p35 gene homologue but encodes three iap genes designated as hycuiap1, hycu-iap2, and hycu-iap3. Functional analysis of these iap genes by transient expression assay demonstrates that only Hycu-IAP3 is capable of blocking apoptosis of Sf9 cells induced by actinomycin D (ActD) and p35-deficient AcMNPV (AcMNPVDp35). Our results also show that knockdown of hycu-iap3 expression by hycu-iap3 dsRNA results in the apoptosis of HycuNPV-infected SpIm cells, indicating that Hycu-IAP3 is an indispensable anti-apoptotic protein for HycuNPV productive infection of SpIm cells.
Results

Inhibition of ActD-induced apoptosis of SpIm cells by HycuNPV infection
To examine whether HycuNPV induces anti-apoptotic activity through infection, SpIm cells were mock-infected or infected with HycuNPV and at different times postinfection (pi), cells were treated with ActD for 24 h. The results showed that almost all the mock-infected cells were broken into apoptotic bodies, producing apoptotic DNA fragments (Fig. 1) . Apoptotic body formation and apoptotic DNA fragmentation were also detected in cells treated with ActD at 0 h pi. On the other hand, HycuNPV-infected cells treated with ActD at 4 h pi or later did not undergo apoptosis and showed no apoptotic DNA fragmentation (Fig. 1) . These results indicated that HycuNPV infection induced antiapoptotic activity in SpIm cells as early as 4 h pi.
Identification and structural analysis of HycuNPV iap genes
To identify anti-apoptotic genes of HycuNPV, HycuNPV genomic DNA was digested with seven different restriction enzymes, EcoRI, HindIII, PstI, SacII, SalI, SpeI, and XhoI, and Southern blot analysis was performed with probes specific to anti-apoptotic genes including p35 (ac-p35) and iap1 (ac-iap1) from AcMNPV and iap2, iap3, and iap4 (op-iap2, op-iap3, and op-iap4, respectively) from OpMNPV. When blots were probed with ac-p35 or opiap4, a positive signal was not detected in HycuNPV genomic DNA fragments. On the other hand, ac-iap1, opiap2, and op-iap3 detected single or divided positive signals in HycuNPV genomic DNA fragments that had been digested with any of the restriction enzymes used (data not shown). When ac-iap1 was used as probe, a 4.7-kbp PstI H fragment (cf. Kamiya et al., 2003) was detected as a positive signal. Nucleotide sequencing showed that the PstI H fragment encoded an HycuNPV homologue of iap1, hycu-iap1, which composed 828 bp encoding a polypeptide of 276 amino acids with a predicted molecular mass of 31.4 kDa ( Fig. 2A) . Hycu-IAP1 shared 81% amino acid sequence identity to Op-IAP1.
When op-iap2 was used as probe, divided fragments of 3.5 and 1.3 kbp were detected in the SacII-digested HycuNPV genome. Nucleotide sequencing showed that Fig. 1 . Anti-apoptotic activity of SpIm cells infected with HycuNPV. SpIm cells were mock-infected (M) or infected with HycuNPV at an MOI of 10 PFU/cell, and at indicated times postinfection (pi), cells were treated with 1 Ag/ml of actinomycin D (ActD) for 24 h. After ActD treatment, cells were collected and apoptotic DNA fragments were extracted. The apoptotic DNA fragments were electrophoresed on 1% SeaKem GTG agarose gel containing EtBr in TBE buffer. 100 base-pair ladder (100 bp) was used as standard. Fig. 2 . Nucleotide sequences and deduced amino acid sequences of hycu-iap1, hycu-iap2, and hycu-iap3. Underlines indicate the BIR domains, BIR1 and BIR2, and double underline indicates the RING finger motif. Early promoter motif, TATA box followed by CA(G/T)T, and late promoter motif, (A/T/G)TAAG, were boxed and shaded, respectively. these fragments encoded a homologue of iap2, hycu-iap2, that composed 729 bp encoding a polypeptide of 243 amino acids with a predicted molecular mass of 27.3 kDa (Fig. 2B) . Hycu-IAP2 shared 71% amino acid sequence identity to Op-IAP2.
Similarly, op-iap3 detected a 3.3-kbp HindIII M fragment (cf. Kamiya et al., 2003) that encoded a homologue of iap3, hycu-iap3. hycu-iap3 composed 789 bp that encoded a polypeptide of 263 amino acids with a predicted molecular mass of 30.2 kDa (Fig. 2C) . Hycu-IAP3 shared 62% amino acid sequence identity to Op-IAP3. Hycu-IAP3 also shared higher identities to functional IAPs, with 55%, 57%, 57%, and 56% amino acid sequence identities to Cp-IAP3, B. mori IAP, T. ni IAP, and S. frugiperda IAP, respectively. The identities between Hycu-IAP1 and Hycu-IAP2, Hycu-IAP1 and Hycu-IAP3, and Hycu-IAP2 and Hycu-IAP3 were 14%, 26%, and 17%, respectively. All these Hycu-IAPs contained two BIR domains at the N-terminal portion and a RING finger motif at the C-terminus (Figs. 2 and 3 ).
hycu-iap expression during HycuNPV infection
The expression of hycu-iap genes in SpIm cells infected with HycuNPV was examined by Northern blot analysis (Fig. 4) . When hycu-iap1 was used as probe, a 1.5-kb transcript was first detected at 12 h pi, increased until 36 h pi, and then decreased gradually (Fig. 4A) . A similar expression profile was observed in hycu-iap2, in which a 1.3-kb transcript was first detected at 16 h pi, reached a maximum level at 48 h pi, and then decreased slightly (Fig. 4B) . When hycu-iap3 was used as probe, 1.4-and 0.9-kb transcripts were first detected at 4 h pi and increased until 16 h pi (Fig. 4C) . At 16 h pi, the signal of the 0.9-kb transcript determined by BAS2000 imaging analyzer was twice as strong as that of the 1.4-kb transcript. Both transcripts decreased quickly at 24 h pi and remained at this low level thereafter. The appearance of hycu-iap3 expression at 4 h pi was well correlated with the appearance of anti-apoptotic activity in HycuNPV-infected SpIm cells (cf. Fig. 1 ).
The accumulation of Hycu-IAP proteins in HycuNPVinfected SpIm cells was examined by immunoblot analysis using antibodies against Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3 (Fig. 5) . Hycu-IAP1 and Hycu-IAP2 were identified as 33-and 27.5-kDa proteins, respectively, and were first detected at 16 h pi, increased to 36 h pi, and then decreased gradually until 72 h pi (Figs. 5A and B) . A different accumulation pattern was observed in Hycu-IAP3, in which a 28-kDa protein was first detected at 12 h pi, increased to 16 h pi, decreased slightly to 48 h pi, and then became barely detectable by 72 h pi (Fig. 5C ).
Suppression of ActD-induced apoptosis by Hycu-IAPs
To examine whether the Hycu-IAPs have the ability to block ActD-induced apoptosis, Sf9 cells were transfected with pIE/HAhycu-iap1, pIE/HAhycu-iap2, and pIE/ HAhycu-iap3, that expressed Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3, respectively. To facilitate detection of Hycu-IAP proteins, HA tag was fused to the N-terminus of each Hycu-IAP. At 48 h after the transfection, Sf9 cells were harvested and HA-tagged Hycu-IAPs expressed in the cells were examined by immunoblot analysis (Fig. 6A ). Polypeptides of 35, 28, and 34 kDa were detected in cells transfected with pIE/HAhycu-iap1, pIE/HAhycu-iap2, and pIE/HAhycu-iap3, respectively, under the control of AcMNPV ie1 promoter (Fig. 6A ). The expression level of HAHycu-IAP2 was about 50 times lower than those of HAhycu-IAP1 and HAhycu-IAP3. A minor band of approximately 41 kDa was also detected in cells transfected with pIE/HAhycu-iap3. To examine the anti-apoptotic activity of these proteins, Sf9 cells transfected with each of three pIE/HAhycu-iap constructs or pIE/egfp that expressed EGFP were incubated with ActD for 6 h and the percentage of surviving cells was determined by laser scanning cytometer ( Fig. 6B) . A significantly greater percentage of surviving cells was observed in the culture transfected with pIE/ HAhycu-iap3 as compared with that in the mock-transfected culture or those in cultures transfected with pIE/HAhycuiap1, pIE/HAhycu-iap2, and pIE/egfp (Fig. 6B ). To see if the anti-apoptotic activity is dependent on the level of Hycu-IAP3 expression, different amounts (from 0.1 to 8 Ag) of pIE/HAhycu-iap3 were transfected into Sf9 cells and transfected cells were treated with ActD for 6 h. Immunoblot analysis showed that the level of Hycu-IAP3 expression increased with increasing amounts of transfected DNA in a range from 0.1 to 2 Ag but decreased slightly at 8 Ag (Fig.  7A ). The percentage of surviving cells increased with increasing amount of transfected pIE/HAhycu-iap3 in a range from 0.1 to 2 Ag, exhibiting maximal apoptosis inhibition activity at 2 Ag (Fig. 7B ).
Rescue of NPV-induced apoptosis by Hycu-IAPs
To see whether Hycu-IAPs have ability to rescue NPVinduced apoptosis, Sf9 cells were co-transfected with AcMNPVDp35 DNA and each of pIE/HAhycu-iap1, pIE/ HAhycu-iap2, and pIE/HAhycu-iap3, and transfected Sf9 cells were examined for apoptosis and cytopathology under a microscope (Fig. 8) . When Sf9 cells were transfected with AcMNPVDp35 DNA only, apoptosis was observed by 24 h post-transfection and most transfected Sf9 cells underwent apoptosis by 72 h post-transfection (Fig. 8A) . A similar apoptotic response was observed in Sf9 cells co-transfected with AcMNPVDp35 DNA and pIE/HAhycu-iap2 (Fig. 8C) . Fig. 4 . Northern blot analysis of hycu-iap1, hycu-iap2, and hycu-iap3 gene expressions. Total RNA was extracted from HycuNPV-infected SpIm cells at 0, 4, 6, 8, 12, 16, 24, 36, 48 , and 72 h pi and separated on 1.2% agaroseformaldehyde gel. The RNA on the gel was transferred to a Hybond-N+ membrane and probed with 32 P-labeled PCR-products specific for hycuiap1 (A), hycu-iap2 (B), and hycu-iap3 (C). Molecular sizes of hycu-iap1, hycu-iap2, and hycu-iap3 mRNAs are indicated on the right, and molecular size markers on the left. , 4, 8, 12, 16, 24, 36, 48, 60 , and 72 h pi were separated on 12.5% polyacrylamide gel and blotted onto Immobilon transfer membranes. Hycu-IAP1 (A), Hycu-IAP2 (B), and Hycu-IAP3 proteins (C) were probed by antisera against Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3, respectively, and visualized by goat anti-mouse IgG antibody conjugated with horseradish peroxidase and ECL. The approximate molecular mass of each Hycu-IAP is indicated on the right.
In the culture co-transfected with AcMNPVDp35 DNA and pIE/HAhycu-iap1, a few growing cells besides apoptotic cells were observed at 72 h (Fig. 8B) , but most cells underwent apoptosis by 96 h (data not shown). No detectable production of polyhedra was observed in cells undergoing apoptosis that had been co-transfected with AcMNPVDp35 DNA and pIE/HAhycu-iap1 or pIE/ HAhycu-iap2. In contrast, in the culture co-transfected with AcMNPVDp35 and pIE/HAhycu-iap3, less than 1% of cells underwent apoptosis and approximately 30% of cells produced polyhedra by 72 h (Fig. 8D) , and the number of cells producing polyhedra increased at 96 h. These results indicated that Hycu-IAP3 was capable of blocking apoptosis of Sf9 cells induced by AcMNPVDp35.
Knockdown of hycu-iap3 expression during HycuNPV infection
To examine if the anti-apoptotic activity of Hycu-IAP3 is essential for productive infection of HycuNPV in SpIm cells, knockdown of hycu-iap3 expression was carried out by hycu-iap3 dsRNA. The effect of hycu-iap3 dsRNA on hycu-iap3 expression was first examined in Sf9 IAP3 cell line that stably expressed HA-tagged Hycu-IAP3. Sf9
IAP3 cells were transfected with 0.5, 2, and 5 Ag of hycu-iap3 dsRNA and at 3 days post-transfection, the cells were examined for Hycu-IAP3 expression by immunoblot analysis. The results showed that hycu-iap3 dsRNA strikingly reduced Hycu- (Fig. 9A) . To examine whether dsRNA-dependent RNAi performs successfully in SpIm cells as well, 2 Ag of plasmid encoding luciferase, pHyHr6IE1/Luc, was co-transfected with 0.5, 2, or 10 Ag of luciferase dsRNA, and the co-transfected SpIm cells were incubated for 2 days. The cell extracts showed that luciferase dsRNA reduced luciferase activity in a dosedependent manner, while hycu-iap3 dsRNA used as a negative control did not reduce the luciferase activity at all (Fig. 9B) . These results suggested that hycu-iap3 dsRNA could be used to suppress Hycu-IAP3 expression in SpIm cells infected with HycuNPV.
To examine whether suppression of hycu-iap3 expression during HycuNPV infection induced apoptosis of HycuNPVinfected SpIm cells, the cells co-transfected with HycuNPV DNA and hycu-iap3 dsRNA were examined under a microscope. Most of the co-transfected SpIm cells formed apoptotic bodies at 5 days post-transfection (Fig. 10Ac) . In contrast, apoptotic bodies were observed in few, if any, cells when transfected with HycuNPV DNA alone (Fig. 10Ae) or co-transfected with HycuNPV DNA and each of hycu-iap1 dsRNA, hycu-iap2 dsRNA, or luciferase dsRNA (Figs.  10Aa, b, d) . The DEVD-cleavage activity assay in transfected cells showed that caspase-3-like protease activity increased significantly only in SpIm cells co-transfected with HycuNPV DNA and hycu-iap3 dsRNA (Fig. 10B) , suggesting that apoptosis of HycuNPV-infected SpIm cells induced by knockdown of hycu-iap3 expression by hycuiap3 dsRNA was associated with activation of caspase-3-like protease.
Discussion
In this study, we have focused on HycuNPV anti-apoptotic genes and demonstrated that HycuNPV contains homologues of three members of iap. These three HycuNPV iap homologues were designated as hycu-iap1, hycu-iap2, and hycu-iap3 because of their amino acid sequence homology with other iaps identified previously in CpGV (Crook et al., 1993) , AcMNPV , OpMNPV (Birnbaum et al., 1994) , and EppoMNPV (Maguire et al., 2000) . Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3 showed the highest homology with corresponding OpMNPV IAPs, exhibiting 81%, 71%, and 62% amino acid sequence identities with Op-IAP1, Op-IAP2, and Op-IAP3, respectively. Such high identity between HycuNPV and OpMNPV observed IAPs is consistent with the results of other viral proteins including GP64 and PCNA (Felipe Alves et al., 2002a; Iwahori et al., 2002) . Like other baculovirus IAPs, Hycu-IAPs possess two BIR domains in the N-terminal region and a single RING finger motif in the C-terminal region. In the promoter region, along with one TATA box, hycu-iap3 has both early and late transcription initiator motifs, whereas only late transcription initiator motif is found in hycu-iap1 and hycu-iap2. Consistent with such promoter organization, our results from analyses by Northern blotting and immunoblotting showed that expression of hycu-iap3 initiated earlier after infection than expressions of hycu-iap1 and hycu-iap2 in the HycuNPVinfected SpIm cells.
In accordance with the results in OpMNPV (Means et al., 2003) , our results from RNAi assays showed that knockdown of hycu-iap3 expression induced apoptosis of HycuNPV DNA-transfected SpIm cells, while introduction of dsRNAs against hycu-iap1 and hycu-iap2 into HycuNPV DNA-transfected SpIm cells did not trigger apoptosis. These results indicate that hycu-iap3 is indispensable for HycuNPV to resist apoptosis induction to maximize the yield of progeny virions in conventional host SpIm cells. In addition, our results from transient expression assays in Sf9 cells revealed that Hycu-IAP3 blocked apoptosis induced not only by ActD but also by infection with p35-deficient AcMNPV, AcMNPVDp35, while Hycu-IAP1 and Hycu-IAP2 exhibited no detectable anti-apoptotic activity. Taken together, such functional analyses of Hycu-IAPs indicate that only hycu-iap3 encodes functional anti-apoptotic protein while hycu-iap1 and hycu-iap2 code for proteins not functional in blocking apoptosis. It is thus probable that the anti-apoptotic activity presented in this study in HycuNPVinfected SpIm cells is attributed to hycu-iap3.
Our results showed that neither Hycu-IAP1 nor Hycu-IAP2 was capable of blocking apoptosis of Sf9 cells induced by ActD and AcMNPVDp35. In a preliminary study, we have found that expression of Hycu-IAP1 in AcMNPVDp35 DNA-transfected Sf9 cells significantly increased the extent of apoptosis induction up to 24 h post-transfection compared with that of Sf9 cells transfected with AcMNPVDp35 DNA alone (data not shown). In addition, recent studies in our laboratory have shown that overexpression of Hycu-IAP1 alone induces apoptosis in a significant number of cells in culture of several different insect cell lines, including Sf9, Ld652Y, TN368, and Drosophila S2 (Ikeda, unpublished). While apoptosisinducing activity has not been reported for full-length IAPs so far identified, portions of baculovirus IAP sequences that include BIR domains of Op-IAP3 and Cp-IAP3, or RING finger motif of Cp-IAP3 have been shown to trigger apoptosis of Sf21 cells (Harvey et al., 1997) . Furthermore, it has been shown that truncated Op-IAP3 protein defective in RING finger motif sequence sensitizes Sf21 cells to apoptosis induction (Hozak et al., 2000) . Because Hycu-IAP1 is expressed only late in HycuNPV infection of SpIm cells, it is possible that Hycu-IAP1 induces apoptosis late in infection. This may facilitate cell-to-cell dissemination of progeny virions within an individual insect (Alnemri et al., 1992; Teodoro and Branton, 1997) . Such speculation is consistent with the previous suggestion that apoptosis induced by NPV infection could be triggered by late events as well as early events of virus infection (LaCount and Friesen, 1997).
Our results showed that the amount of Hycu-IAP2 accumulated in Sf9 cells transfected with pIE/HAhycuiap2 was about 50 times lower than those of Hycu-IAP1 and Hycu-IAP3 accumulated after transfection with pIE/ HAhycu-iap1 and pIE/HAhycu-iap3, respectively. Because expression from these three plasmids is driven by the same AcMNPV ie1 promoter, it is likely that the Hycu-IAP2 protein is less stable and degraded more quickly compared with Hycu-IAP1 and Hycu-IAP3 proteins. It was recently demonstrated that BmNPV IAP2 (Bm-IAP2) with a RING finger motif functions as ubiquitin ligase (RING E3) that is able to be ubiquitinated by itself in in vitro ubiquitination assay (Imai et al., 2003) . The RING finger motif of Bm-IAP2 was very similar to that of Hycu-IAP2 and shared 83% amino acid sequence identity. Thus, it is possible that Hycu-IAP2 has ubiquitin ligase activity. Hycu-IAP2 may catalyze autoubiquitination and ubiquitinated Hycu-IAP2 is eliminated by a ubiquitin-dependent degradation system (Pickart, 2001) .
Our results in this study together with the results from P35 of AcMNPV (Clem et al., 1991) and Op-IAP3 of OpMNPV (Means et al., 2003) provide evidence that the presence of anti-apoptotic proteins is essential to circumvent cellular apoptosis induction and to optimize baculovirus multiplication in permissive host cells. In addition, we have suggested that certain baculovirus IAPs potentially have functional roles during baculovirus infection that are distinct from those of anti-apoptotic proteins. Further analyses to address these issues are currently in progress in our laboratory using various cell lines infected with a variety of NPV species.
Materials and methods
Viruses, cells, and infection
Plaque-purified NPV clones from H. cunea (HycuNPV N9; Kamiya et al., 2003) , A. californica (AcMNPV E2; Smith and Summers, 1978) , and O. pseudotsugata (OpMNPV; Bradford et al., 1990; Quant-Russell et al., 1987) were used. A mutant AcMNPV defective in p35, vP35delBsu36Igus (AcMNPVDp35), was obtained from Dr. Rollie J. Clem (Kansas State University, Manhattan, KS). FRI-SpIm-1229 (SpIm) cells derived from Spilosoma imparilis (Mitsuhashi and Inoue, 1988) were grown in monolayer culture in MM medium (Mitsuhashi and Maramorosch, 1964) supplemented with 3% fetal bovine serum (FBS). Sf9 cells derived from S. frugiperda were maintained in Grace's medium (Invitrogen, Carlsbad, CA) supplemented with 10% FBS. Unless otherwise stated, monolayer cultures of these cells were infected with viruses at an input multiplicity of infection (MOI) of 5 plaque-forming units (PFU) per cell. After a 60-min adsorption period at room temperature, the inoculum was replaced by appropriate fresh medium and incubated at 28 jC.
Actinomycin D treatment and DNA ladder analysis
Actinomycin D (ActD) stock solution (5 mg/ml) was prepared and diluted in appropriate culture media to desired concentrations before used. SpIm cells (1 Â 10 6 ) in 12.5-mm 2 flasks (Falcon 3018; Becton Dickinson Labware, Franklin Lakes, NJ) were mock-infected or infected with HycuNPV at an MOI of 10 PFU per cell and at different times postinfection (pi). These cells were treated with 2 ml of ActD at a concentration of 1 Ag/ml for 24 h at 28 jC. Sf9 cells (1 Â 10 6 ) in 35-mm dishes (Falcon 3001) were transfected with plasmid DNAs, and at 48 h post-transfection, they were treated with 1 ml of ActD at 0.5 Ag/ml at 28 jC for 6 h.
ActD-treated cells were collected by low-speed centrifugation and washed with PBS (2.7 mM KCl, 1.5 mM KH 2 PO 4 , 137 mM NaCl, 8 mM Na 2 HPO 4 ). Apoptotic DNA fragments in ActD-treated cells were extracted in NP40 lysis buffer (1% NP40, 20 mM EDTA, 50 mM Tris -HCl, pH 7.5) and analyzed by a 1% SeaKem GTG agarose (FMC BioProducts, Rockland, ME) gel as described previously (Ishikawa et al., 2003) . 100 base-pair Ladder (Amersham Biosciences Corp., Piscataway, NJ) was used as DNA size marker.
Laser scanning cytometry analysis
To determine the percentage of surviving cells after ActD-treatment, laser scanning cytometry analysis was carried out. Two sets of parallel cell cultures were transfected with the plasmid construct of interest, and at different times after the transfection, one culture received ActD treatment while the other culture was not treated with ActD. The cells with or without ActD treatment were scraped by rubber policeman and seeded on a collagenized cover glass (Collagen type I-coated cover glass, Iwaki, Tokyo, Japan). These cells were then washed with PBS containing 1 mM CaCl 2 and 1 mM MgCl 2 (PBS(+)) and fixed with 2% paraformaldehyde in PBS(+) for 10 min. The fixed cells were incubated for 30 min at 37 jC with propidium iodide (50 Ag/ml PBS) containing RNase A (200 Ag/ml), mounted with Vectashield mounting medium (Vector Laboratories Inc., Burlingame, CA), and covered with a slide glass. The viable cells stained with propidium iodide were counted in three different areas of 2 Â 2 mm (>2000 cells) from cultures with or without ActD treatment by laser scanning cytometer (LSC101, Olympus, Tokyo, Japan) and the percentage of survival cells that resisted apoptosis was determined by dividing the number of viable cells from ActDtreated culture by those from the parallel culture without ActD treatment.
Viral DNA isolation and Southern blot analysis
HycuNPV genomic DNA was extracted from HycuNPVinfected SpIm cells as described previously (Laviña et al., 2000) . Viral DNA (1-2 Ag) was digested with restriction endonucleases and DNA fragments produced were separated on 0.8% SeaKem GTG agarose gel. The DNA fragments on the gel were blotted onto a Hybond-N+ nylon membrane (Amersham Biosciences Corp.) and hybridized with probes. p35 and iap1 of AcMNPV (ac-p35 and ac-iap1, respectively) and iap2, iap3, and iap4 of OpMNPV (op-iap2, op-iap3, and op-iap4, respectively) were PCR-amplified using AcMNPV or OpMNPV genome DNA as the template and specific paired primers: 5 V-CCGGTAGAAATC-GACGTGTC-3Vand 5V-GCCCCAGCTCGATTCTGTAG-3V for ac-p35; 5V-CGTGTGTGACAACTTTCGCG-3V and 5V-CGGTTGACGTCCTGACGACAC-3V for ac-iap1; 5V-CACGATGTCCTTCATGTCGC-3V and 5V-TTGAGG-GATGGTGCTGAGGC-3V for op-iap2; 5V-TGAGCTCCC-G A G C A A T T G G C -3 V a n d 5 V-C T T G G T A C ATGCGCACCGCT-3V for op-iap3; and 5V-AAAGGT-GAACGGCAGGCTGC-3V and 5V-GCCTATGCGA-TAACTGCACG-3V for op-iap4. PCR products were labeled with Gene Images random prime labeling module (Amersham Biosciences Corp.). Hybridized DNA fragments were processed by Gene Images CDP-Star detection module (Amersham Biosciences Corp.) and visualized by exposing onto X-ray films (Fuji Photo Film, Tokyo, Japan).
DNA cloning and sequencing
Viral DNA fragments were subcloned into pBluescript KS (+) (pBS; Stratagene, La Jolla, CA) and transformed into XL1-blue (Stratagene). The plasmid DNA was extracted by Flexiprep DNA purification kit (Amersham Biosciences Corp.) and used for the sequence reaction by Big Dye terminator sequencing reaction mix (Applied Biosystems, Foster City, CA) according to the manufacturer's protocol. The nucleotide sequence was determined by ABI PRISM 310 genetic analyzer (Applied Biosystems) and connected by DNASIS (Hitachi, Yokohama, Japan).
RNA isolation and Northern blot analysis
Total RNA was isolated from virus-infected cells with TRIzol reagent (Invitrogen) according to the manufacturer's instruction and dissolved in 0.5% SDS. The RNA samples (20 Ag/lane) were denatured, electrophoresed in 1.2% agarose gel (4% formaldehyde, 100 mM MOPS, 25 mM CH 3 COONa, 5 mM EDTA), and blotted onto a Hybond-N+ nylon membrane (Amersham Biosciences Corp.) in 5 mM NaOH as described previously (Ishikawa et al., 2003) . The RNA on the membrane was hybridized with specific probes that were labeled with [a- 32 P]dCTP (NEN Life Science Products, Boston, MA) by the rediprime random prime labeling system (Amersham Biosciences Corp.). The probe DNAs used for 32 P-labeling were prepared by PCR using HycuNPV genomic DNA as template and three paired primers: hycu-iap1, sense primer 65 -84 and antisense primer 791 -810; hycu-iap2, sense primer 72 -91 and antisense primer 705 -724; hycu-iap3, sense primer 5-24 and antisense primer 743 -762 (hycuiaps nucleotide numbers, see Fig. 2 ). Hybridized probes were visualized by a BAS 2000 imaging analyzer (Fuji Photo Film).
Plasmids pIE/HAhycu-iap1, pIE/HAhycu-iap2, and pIE/HAhycuiap3 used in transient expression assay were constructed by inserting PCR-amplified hemaglutinine (HA)-tagged hycu-iap genes into BamHI -NotI sites of the pIE1-2 (Novagen, Darmstadt, Germany). HA-tagged hycu-iap1, hycu-iap2, and hycu-iap3 were amplified by using pHyHr6IE1/HAhycu-iap1, pHyHr6IE1/HAhycu-iap2, and pHyHr6IE1/HAhycu-iap3 as the templates, respectively, and 5V-GGATCCCATGTACCCATACGA-3V and 5V-GTCTGCTCGAAGCGGGCGGC-3V as a 5V primer and a 3V primer, respectively. pHyHr6IE1/HAhycu-iap1, pHyHr6IE1/HAhycu-iap2, and pHyHr6IE1/HAhycu-iap3 were constructed from pHyHr6IE1/Luc (Felipe Alves et al., 2002b) by replacing the luciferase ORF within NcoIXbaI sites with ORFs of hycu-iap1, hycu-iap2, and hycuiap3, respectively. The ORFs of hycu-iap1, hycu-iap2, and hycu-iap3 were amplified by PCR using HycuNPV genomic DNA as a template and paired primers with NcoI, SpeI, and XbaI restriction sites (underlined); Hciap1F (5V-ACTGACACCATGG ACGCGCC-3V) and Hciap1R (5V-TTGCAACTAGTTCATACCAC-3V); Hciap2F (5V-GCAATTAACCATGGATTTGC-3V) and Hciap2R (5V-GTGGTCTAGA CTTATTACTG-3V); and Hciap3F (5V-GTGTTACCATGG ACGCACAC-3V) and Hciap3R (5V-CTCGTCTAGA TTAATAATAC-3V), respectively. For the addition of HA tag at the N-terminus of Hycu-IAPs, a NcoI adapter with HA tag was constructed by annealing 5V-CATGGTAGCGTAATCCGGAACATCGTATGGGTA-3V and 5V-CATGTACCCATACGATGTTCCGGATTACGC-TAC-3V that contained translation initiation codon (underlined). The NcoI adapter with HA tag was inserted into the NcoI site of each pHyHr6IE1/hycu-iap plasmid.
pIE/egfp was constructed by inserting the egfp gene into BamHI -NotI sites of pIE1-2. The egfp gene was prepared by digesting pBac[3xP3-EGFPafm] (Horn and Wimmer, 2000) with BamHI and NotI.
pIZhycu-iap3 was constructed by inserting hycu-iap3 into NcoI-XbaI sites of pIZ/V5-His (Invitrogen). NcoI adapter with HA tag was inserted at the NcoI site of the N-terminal of hycu-iap3 gene. The hycu-iap3 was derived upon digestion of pHyHr6IE1/HAhycu-iap3 with NcoI and XbaI All plasmid constructs were transformed into XL1-blue (Stratagene). The plasmid DNAs were isolated by Midi prep kit (Qiagen, Hilden, Germany) or Geno pure plasmid midi kit (Roche Diagnostics GmbH, Mannheim, Germany).
Preparation of stably expressing cell lines
For selecting cells stably expressing Hycu-IAP3, Sf9 cells were transfected with pIZhycu-iap3 and incubated in medium containing 0.2 mg/ml of Zeocin (Invitrogen). A stably expressing clonal cell line, Sf IAP3 , was isolated according to the method described in the manufacturer's protocol.
Immunoblot analysis
Polypeptides from infected or transfected cells were resolved by SDS-polyacrylamide gel electrophoresis according to the method of Laemmli (1970) and transferred onto an Immobilon transfer membrane (Millipore, Bedford, MA) or a nitrocellulose membrane (Advantec Toyo, Tokyo, Japan) with the aid of Horizblot (Atto, Tokyo, Japan) for 90 min at 200 mA as described previously (Laviña et al., 2000) . The blots were probed with antibodies against HA, Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3 and reacted with goat anti-mouse IgG antibody conjugated with horseradish peroxidase (Zymed Laboratories, San Francisco, CA). Positive signals were visualized by ECL (Amersham Biosciences Corp.). BenchMark pre-stained protein ladder (Invitrogen) was used as protein size marker.
Anti-HA monoclonal antibody HA.11 was purchased from Babco (Richmond, CA). The antibodies against Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3 were raised in mouse as described previously (Ishikawa et al., 2003) using portions of each Hycu-IAP protein generated by pET-32b(+) expression vector (Novagen). For the construction of vectors expressing Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3 proteins, three sets of paired primers with HindIII and XhoI restriction sites (underlined); 5V-CGGGATCC CGTGAT-CAATATATGTGC-3Vand 5V-CCGCTCGAGCGGATCTTT-GAAGGT-3V; 5V-CGGGATCCCGTGGATTTGCAA-3Vand 5V-CCGCTCGAG CGGCAAGGTGTTTATG-3V; and 5V-CGGGATCC CGGAGTTAACATGGAA-3V and 5V-CGGCTCGAG CGGGTAATAAAACCC-3, respectively, were used. dsRNA production and RNAi procedure dsRNAs of hycu-iap and luciferase genes were prepared as described previously (Clemens et al., 2000) . Briefly, 631 bp of hycu-iap1, 607 bp of hycu-iap2, 674 bp of hycu-iap3, and 677 bp of luciferase were amplified by PCR using pIE1/ HAhycu-iap1, pIE1/HAhycu-iap2, pIE1/HAhycu-iap3, and pGL-Basic vector (Promega, Madison, WI) as the templates, respectively, and four pairs of PCR primers that contained a 5V T7 RNA polymerase binding site (GAATTAATAC-GACTCACTATAGGGAGA) followed by sequences specific for the target genes. Target gene specific primer sequences were as follows: hycu-iap1, sense primer 42-56 and antisense primer 658 -672; hycu-iap2, sense primer 35 -49 and antisense primer 627 -641; hycu-iap3, sense primer 43 -57 and antisense primer 702 -716 (hycu-iaps nucleotide numbers, see Fig. 2) ; luciferase in the pGL3-Basic vector, sense primer 122 -136 and antisense primer 784 -798. PCR products were purified by using Quick spin column G-50 (Roche Diagnostics GmbH). Sense and antisense RNAs were transcribed by using purified PCR products as templates and Megascript T7 transcription kit (Ambion, Austin, TX), and annealed by incubation at 65 jC for 30 min, followed by slow cooling at room temperature. dsRNAs were introduced into cells by transfection (Katou et al., 2001 ).
Transfection and assay of luciferase and caspase-3-like protease activities Transfection was performed in cells (1 Â 10 6 ) in 35-mm tissue culture dishes (Falcon 3001) with indicated amounts of plasmid DNA or the mixture of 2 Ag of plasmid DNA and 1 Ag of NPV DNA by using 10 Al of Lipofectin (Invitrogen) as described previously (Katou et al., 2001) .
Luciferase activity was determined by using Bright-Glo luciferase assay system (Promega) as described previously (Felipe Alves et al., 2002b) . Caspase-3-like protease activity was assayed by using caspase-3 fluorescent assay kit, ApoProbe-3 (BioDynamics Laboratory Inc., Tokyo, Japan) as described previously (Ishikawa et al., 2003) .
